Literature DB >> 3524429

Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

P R Meylan, G Braoudakis, M P Glauser.   

Abstract

An acute exudative Escherichia coli pyelonephritis rat model was used to study the influence of progressive pyelonephritis on the efficacy of antibiotic treatment. In this model, transient ureteral obstruction after E. coli bladder inoculation induces early bacterial multiplication in the kidney parenchyma, and the bacterial counts peak by 48 h. The inflammatory response (assessed by the increase in kidney weight) is somewhat delayed, starting 36 h after inoculation and peaking by 72 h. Groups of rats received 4 doses over 48 h of saline, ceftriaxone (100 mg/kg), or ceftriaxone (100 mg/kg) plus gentamicin (4 mg/kg). These treatments were initiated 24, 36, 48, or 72 h after bladder inoculation. Antibiotic treatment started at 24 h was significantly more effective in reducing bacterial counts in the kidney parenchyma than at any later therapy onset. Only when started 24 h after inoculation was the synergistic combination of ceftriaxone plus gentamicin more effective in reducing bacterial counts than ceftriaxone alone. Ceftriaxone and ceftriaxone plus gentamicin regimens started at 24 h reduced significantly (by 42 and 55%, respectively) the incidence of acute exudative pyelonephritis when compared with the incidence in saline-treated controls. Early therapy onset (24 h) strikingly reduced the development of the inflammatory response. This reduction was less marked when antibiotic therapy was started at 36 h and no longer apparent when therapy onset was delayed up to 48 or 72 h. In conclusion, the efficacy of antibiotics in eradicating bacteria from the kidney parenchyma and in preventing acute exudative pyelonephritis was markedly hampered by the development of pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524429      PMCID: PMC284150          DOI: 10.1128/AAC.29.5.760

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Suppression of lytic effect of beta lactams on Escherichia coli and other bacteria.

Authors:  E W Goodell; R Lopez; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

Review 2.  Anaerobic infections (third of three parts).

Authors:  S L Gorbach; J G Bartlett
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

3.  Increasing the usefulness of antibiotics: Treatment of infections caused by gram-negative bacilli.

Authors:  L D Sabath; D A Gerstein; C D Leaf; M Finland
Journal:  Clin Pharmacol Ther       Date:  1970 Mar-Apr       Impact factor: 6.875

4.  Chronic interstitial nephritis: etiologic factors.

Authors:  T Murray; M Goldberg
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

5.  Alteration of effectiveness of antibiotics by anaerobiosis.

Authors:  R M Verklin; G L Mandell
Journal:  J Lab Clin Med       Date:  1977-01

6.  Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.

Authors:  J P O'Keefe; F P Tally; M Barza; S L Gorbach
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

7.  Interaction of purulent material with antibiotics used to treat Pseudomonas infections.

Authors:  R E Bryant; D Hammond
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Immunization against retrograde pyelonephritis. III. Vaccination against chronic pyelonephritis due to Escherichia coli.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

9.  Immunization against retrograde pyelonephritis. I. Production of an experimental model of severe ascending Escherichia coli pyelonephritis without bacteremia in rats.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

10.  Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.

Authors:  S J Brooks; J M Lyons; A I Braude
Journal:  Am J Pathol       Date:  1974-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.